Top Markets
Coin of the day
GH Research PLC GH Research PLC

GH Research PLC

GHRS
Peringkat dalam Saham #6594
GH Research PLC is a clinical-stage biopharmaceutical firm dedicated to... GH Research PLC is a clinical-stage biopharmaceutical firm dedicated to creating novel therapies for psychiatric and neurological conditions. The company primarily concentrates on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) treatments, specifically targeting patients with treatment-resistant depression (TRD). Its most advanced program is GH001, an inhalable 5-MeO-DMT product candidate that has successfully completed two Phase 1 clinical trials and a subsequent Phase 1/2 clinical trial in TRD patients. Additionally, GH Research is developing GH002, an injectable 5-MeO-DMT candidate, and GH003, an intranasal 5-MeO-DMT candidate. Both GH002 and GH003 are currently in preclinical development, with a focus on their potential applications in various psychiatric and neurological disorders. Founded in 2018, GH Research PLC is headquartered in Dublin, Ireland.
Harga Saham
$28.53
Terakhir disinkronkan: 2026-08-27
Kapitalisasi Pasar
$1.96B
Perubahan (1 hari)
-1.65%
Perubahan (1 tahun)
106.14%
Negara
IE
Perdagangan GH Research PLC (GHRS)

Kategori

Riwayat pemecahan saham untuk GH Research PLC (GHRS)
Saham GH Research PLC (simbol: GHRS) telah mengalami total 0 kali pemecahan saham.
Pemecahan saham terbaru terjadi pada Aug 28, 2026.
Satu lembar saham GHRS yang dibeli sebelum Aug 28, 2026 sekarang setara dengan 0 lembar saham GHRS.
Daftar pemecahan saham
Tahun Pemecahan Kelipatan Kelipatan Kumulatif
Tidak cukup data untuk tanggal yang disediakan.
Pemecahan saham untuk perusahaan sejenis atau pesaing
Perusahaan Jumlah pemecahan saham Kelipatan Kumulatif Negara
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH